Assessment of DNA Variations From Two In Vivo Skeletal Muscle Disorder Mouse Models Using Complementary Square‐Wave Voltammetry and LC‐MS/MS Analysis Authors: Elizabeth R. LaFave, Grayson B. Sink, Saphal Bhandari, Emma L. Rayfield, Andrew T. Readyoff, Espen E. Spangenburg, Eli G. Hvastkovs Published: 2026 ABSTRACT Duchenne Muscular Dystrophy (DMD) and Ehlers‐Danlos Syndrome (EDS) are characterized by genetic instability due to DNA damage leading to loss of muscular function. Genetic impacts of these diseases were probed by extracting DNA from selected muscle tissues of either a mouse model of X chromosome‐linked muscular dystrophy (mdx, DMD model) or a heterozygous col5a1 (+/‐) mouse (EDS model). Complementary square wave voltammetry (SWV) and liquid chromatography‐tandem mass spectrometry (LC‐MS/MS) approaches were used to assess extracted DNA. SWV analysis was performed by immobilizing DNA layer‐by‐layer (LbL) on pyrolytic graphite (PG) electrodes before oxidation in the presence of Ru(bpy)3 2+. Changes in SWV peak currents (Ip) at ∼+1.05 V vs. SCE indicated significant DNA alterations in the genetically altered mouse tissues compared to wild type (WT) controls. Both mdx and heterozygous col5a1(+/‐) samples exhibited statistically significant decreased Ip levels (p < 0.05) compared to WT DNA suggesting guanine content varied due to the genetic alterations, which was statistically more significant in leg muscle DNA. MS/MS validated and expanded on the SWV results. DNA base analysis showed increased oxidative damage alongside changes in undamaged base content in mdx mice. DNA from col5a1(+/‐) leg muscles exhibited significant changes to undamaged base content, showcasing similar trends. Introduction Duchenne Muscular Dystrophy (DMD) and Ehlers‐Danlos syndrome (EDS) are two distinct genetic disorders that result in abnormal skeletal muscle function characterized by altered cellular physiology and connective tissue abnormalities [1, 2]. DMD is associated with progressive weakening and loss of function in skeletal and cardiac muscles due to loss of dystrophin [1, 3]. The dystrophin glycoprotein complex mechanically protects the sarcolemma against mechanical stress; however, its absence in DMD elicits a cellular crisis that may disrupt DNA repair processes promoting further genetic mutations [1, 4]. EDS is a series of disorders generally characterized by tissue fragility and abnormal healing due to mutations in different collagen gene assemblies [2, 5, 6]. Genes supporting the production of collagen resulting in fibril formation, such as COL5a1, contribute to the formation of type I heterotypic fibrils [7]. Loss of dystrophin expression or irregular collagen fibril formation are both associated with genetic instability [8, 9], implying that irregularities in these proteins promote malignant transformations and further genetic defects [3]. Therefore, it is vital to investigate the genetic basis of these disorders to elucidate mechanisms driving disease progression. Moreover, understanding the interplay between genetic mutations and the resulting cellular and tissue‐level abnormalities is crucial for developing targeted therapies. DNA analysis and damage sequencing methods often require amplification via PCR or short and/or long read sequencing that can prohibit the quantification of DNA damage [10, 11]. PCR is the most common technique due to its simplicity and reliability [10, 12, 13, 14], but can introduce amplification bias [15]. Short read sequencing offers bias improvements but suffers when looking at chimeric DNA or DNA featuring structural variants [14]. Additionally, short read sequencing is generally limited to 500 base pairs making large structural variation percentages of the human genome inaccessible [14]. Long read sequencing can be used to read between 5,000 and 30,000 base pairs [16], and while historically associated accuracy limitations have been largely overcome challenges remain [16]. In particular, long read sequencing requires high concentration, high‐quality, high‐molecular‐weight DNA input, which can be difficult to obtain, which may restrict broad applicability [17, 18, 19]. These techniques often struggle with the analysis of DNA damage and different types of DNA. For instance, PCR often struggles to properly sequence mitochondrial DNA (mtDNA) due to its unique characteristics, such as high mutation rates, heteroplasmy, and the presence of numerous polymorphisms [20]. This is consistent with the high mutation rates shown in many gene editing mouse models (i.e., DMD) [21, 22]. Sensor‐based DNA analyses [23, 24, 25], and especially electrochemical DNA sensors [26], offer solutions to some of these amplification drawbacks when analyzing damaged DNA. Electrochemical sensing approaches have been used to assess metabolite damaged or other oxidatively damaged bases, primarily those of guanine, in complex biological samples [26, 27, 28, 29, 30, 31]. Electrochemical approaches are particularly valuable for analyzing difficult DNA substrates and for detecting low abundance damage that might be missed or distorted by amplification based techniques [26, 32, 33]. Sensor‐based approaches may provide spatial DNA damage distribution information and real‐time analysis capabilities, making them accessible for applications beyond traditional laboratory settings [25, 34, 35, 36]. Many of these approaches utilize mass spectrometry‐based techniques to validate and quantify damaged bases [34, 37, 38]. The ability to directly detect and quantify specific types of DNA damage without amplification represents an approach to complement sequencing methods, offering rapid, structural‐based information coupled with enhanced accuracy and sensitivity for damage quantification studies [34, 37]. We have recently reported using a complementary square wave voltammetry‐tandem mass spectrometry analysis approach that seeks to overcome some genetic analysis limitations by enabling the direct quantification of oxidative lesions and other modified DNA bases, such as oxidatively damaged bases, without the need for DNA amplification [39, 40]. This complementary analysis approach offers a powerful tool for assessing biologically sourced DNA, providing significant insight into disease progression [39, 41]. This approach was effective in elucidating DNA variances in in both mtDNA and nuclear DNA (nDNA) from BRCA1 knockout (KO) compared to wild type (WT) mice and showed that this gene was vital for DNA repair processes [39]. The polymorphic nature of mtDNA poses challenges for traditional sequencing methods [20, 42], yet the assay was utilized to detect increases in mutations and oxidative damage, consistent with traditional genetic assays and observed phenotypic outcomes. Following a similar approach here, total DNA from specific DMD and EDS mouse models was analyzed to provide a more comprehensive understanding of the genetic mechanisms underlying these disorders. Mouse model studies have been used extensively to explore numerous gene correction and targeting strategies in both DMD [43, 44, 45] and EDS [46, 47, 48] models for therapeutic means, as well as further explore genetic and physiological specificities. DNA obtained from these mice was first analyzed via SWV on layer‐by‐layer (LbL) modified graphite electrodes [49, 50]. Electrochemical oxidation of this DNA in the presence of ruthenium catalyst provides a current output that provides information about the base, primarily guanine, content [39, 51, 52]. The rapid assessment of DNA variance via SWV was followed by validation using liquid chromatography‐tandem mass spectrometry (LC‐MS/MS) analysis to identify subtle base compositional changes. These DNA base changes, including the identification of damaged bases, may be overlooked using conventional methods [53, 54]. The ability to simultaneously compare two different disease models provides a unique opportunity to identify common and distinct pathways contributing to genetic instability in these disorders. Experimental Materials Tris buffer was from Fluka, poly(diallyldimethylammonium chloride) (PDDA), poly(sodium 4‐styrenesulfonate) (PSS), and tris(2,2′‐bipyridyl)dichlororuthenium (Ru(bpy)3 2+), formic acid, iron (II) chloride, hydrogen peroxide, acetonitrile, methanol (HPLC Grade), and DNA base standards were from Sigma. Purified 18 MΩ cm−1 DI water was from a Siemens high‐purity water system. All other chemicals for the electrochemical experiments were from Sigma and were reagent grade. DNA Isolation and Preparation The EDS mouse model was generated by haploinsufficiency of the Col5a1 gene, as described by Wenstrup et al. [9] Briefly, a mouse model was employed with a haploinsufficiency of proa(V) chains of type V collagen which results in a 50% reduction in Collagen V across all tissues (kind gift of Louis D. S). The EDS model was maintained in a colony as col5a1(+/+) and col5a1(+/‐), with the latter genotype being a recognized model of classical EDS [9]. In these experiments, skeletal muscle tissue was extracted from 10 to 12 week old male and female col5a1(+/+) (n = 3, WT) and col5a1(+/‐) (n = 3, Het) littermates. In terms of physiological assays, no significant sex‐based differences have been observed in the EDS mice described here (data not shown). Muscle samples were collected from three distinct muscle groups: the extensor digitorum longus (EDL), soleus (SOL), and diaphragm (DIA). We employed mdx and aged matched control mice for mouse models representing DMD. mdx mice lack dystrophin, a critical component of the dystrophin–glycoprotein complex [8]. DNA samples were extracted from gastrocnemius muscles in the leg in 10–12‐week‐old male C57BL/10ScSnJ (BLK/10, n = 3) and C57BL/10ScSn‐Dmd mdx /J (mdx, n = 3) mice obtained from Jackson Laboratory (Bar Harbor, ME). Mice were housed in a temperature (22°C) and light (12/12 h. light/dark) controlled facility and allowed ad libitum access to food and water. All animal procedures and usage were approved by the Institutional Review Committee at East Carolina University, and NRC established animal care guidelines [55]. Total DNA was isolated from the skeletal muscle using QIAamp Fast DNA Tissue Kit (Qiagen, Cat # 51 404). DNA from all mouse models was quantified using a Nanodrop (Thermo) spectrophotometer. Electrode Preparation Pyrolytic graphite (PG, McMaster‐Carr (Elmhurst, IL) source) electrodes (4 mm dia.) were manufactured in‐house and abraded on 800 grit SiC (Buehler) paper followed by rinsing and sonication in DI H2O. After drying under Ar, the electrodes were exposed to the following: PDDA (60 μL droplet, 6 mg mL−1 in DI H2O with 50 mM NaCl) for 15 min followed by PSS (6 mg mL−1 in DI H2O with 50 mM NaCl). These steps were repeated three times. DNA (0.050 mg mL−1 in 10 mM Tris, 10 mM NaCl, pH 7.4) for 30 min was substituted for PSS in the following rounds and was applied for 30 min. The electrode was rinsed with DI water between each layer. The final modified electrode film architecture was (PDDA/PSS)2(PDDA/DNA)2. Electrochemical Measurements All electrochemical measurements were performed using a CH Instruments (Austin, TX) Model 660A potentiostat. Modified electrodes were placed in a standard three‐electrode electrochemical cell (Pt counter, saturated calomel (saturated KCl) reference in 10 mL buffer (10 mM tris, 10 mM NaCl, pH 7.4) with 50 μM Ru(bpy)3 2+. Square‐wave voltammograms (SWVs) were obtained using the following parameters: scan from 0 to + 1.3 V, 15 Hz frequency, 4 mV step height, 25 mV amplitude. LC‐MS DNA Preparation DNA samples (col5a1(+/‐): 0.50 mg mL−1, mdx: 1.00 mg mL−1) were diluted in equal volume of 44% formic acid followed by heating at 120°C for 1 h in 1 mL vacuum hydrolysis tubes. The solutions were then transferred to Amicon Ultra‐0.5 mL 3K filter tubes and centrifuged for 40 min at 30,000 x g. The filtrate was then transferred to LC vials containing 10 μL inserts. LC‐MS/MS Analysis A SciEx 3200 triple quadrupole LC‐MS/MS equipped with a Gemini 3 μm NX‐C18 110 Å LC column (50 x 2 mm) was used. Six MS/MS detection methods were developed using positive ion MRM mode for two characterizing product ions, as summarized in Table S1. Initial analyses centered on guanine monitoring, where a previously employed LC protocol was utilized: Solvent A: 95:5 DI H2O (0.1% formic acid) and acetonitrile and Solvent B: methanol. Gradient elution took place via 100% A 0−3 min, ramp to 75% A min 3−5. The total analysis time was 5 mins. The flow rate was 0.200 mL min−1 and the injection volume was 1.00 μL. Later, an isocratic LC detection method was developed to monitor all four undamaged bases using 0.1% formic acid and 70:25:5 H2O:MeOH:ACN. Total analysis time was 30 min with a flow rate of 0.200 mL min−1 and injection volume of 1.00 μL. Additional LC solvents were Solvent A: 0.1% formic acid, 95:5 DI H2O and acetonitrile, Solvent B: 60:20:20 ACN: Isopropanol: H2O and Solvent C: methanol. Gradient elution took place for both of the damaged bases; 8‐oxoG, 45:50:5 A:B:C for 0–1 mins, decreasing A and increasing C by 5%, respectively, for 1–3 mins, holding 35:50:15 A:B:C for 3–4 mins, ramping to 45:50:5 at 4–6 mins by increasing A and decreasing C by 5%, respectively; and FapyA, 100% B 0–2 min followed by a ramp to 20% C for 2 min and return to 100% B at 5 min. Total analysis time was 5 min for FapyA and 6 min for 8‐oxoG. The flow rate was 0.300 mL min−1 and injection volume was 1.00 μL for both monitored damaged bases. Data Analysis Statistical analysis using unpaired t‐test with Welch's correction, comparing each mutant group to controls, was performed using Excel for MAC 2019, version 16.24 and SCIEX MultiQuant Software, version 3.0. Raw MS and SWV were analyzed using OriginPro 9 software. For SWV plots, background subtraction was performed using the same SWV electrochemical response for a (PDDA/PSS)2 electrode containing no DNA. Figures were modified using Adobe Illustrator CS6. Results Electrochemical Analysis Figure 1 shows a typical baseline adjusted SWV response when thin LbL DNA films are oxidized in the presence of Ru(bpy)3 2+. The use of the transition metal catalyst significantly enhances the sensitivity of this detection approach vs. direct base oxidation via an electrocatalytic cycle according to the following [51, 52]: (a) Representative SWV plots comparing DNA response for WT (black) or mdx KO samples (red). (b) Average Ip at +1.1 V comparing WT to KO. Error bars represent s.d. for n = 3. * denotes statistically significant difference (p < 0.05). Ru(bpy)32+→ Ru(bpy)33++e−(at electrode) Ru(bpy)33++DNA → DNAox•++Ru(bpy)32+ The oxidation potential for the ruthenium catalyst overlaps that of guanine (Eo’ ∼ 1.05V vs. SCE) [51, 52]; therefore, the signal acquired in these types of analyses has been shown to be heavily guanine dependent [51]. Indeed, electrocatalysis of adenine films is virtually non‐existent in the presence of soluble [51] or polymer‐based ruthenium catalysts [56]. Electrochemical oxidation of mdx DNA extracted from leg muscles revealed that KO samples produced significantly lower currents upon oxidation vs. that from WT samples. Figure 1 demonstrates a standard response between genetic KO treatment and WT controls. Here, the SWV comparison is between the KO mdx (red) and WT BLK/10 (black). Figure 1b shows that the average peak current at ∼+1.1 V decreased 25.49 ± 0.40% (p < 0.05) for mdx vs. BLK/10 DNA. The peak current decrease is consistent with guanine content decreases in the KO tissue [39] suggesting that the mdx deficiency is responsible for these DNA variations. Turning to the EDS model, Figure 2 compares DNA extracted from both WT and heterozygous col5a1(+/‐) mice at different muscle locations. Here, DNA was extracted from the DIA, or two locations in the leg: the SOL or EDL. These muscles were selected based on their differing roles and phenotypes, with SOL being a postural slow oxidative muscle, the EDL muscle being a fast glycolytic extensor muscle, and the DIA muscle being the primary muscle responsible for respiration that has a mixed metabolic and contractile phenotype. Figure 2 shows that baseline Ip was not only dependent on tissue type as the same concentration of DNA was immobilized on all electrodes, but that current decreases were clearly more prominent in DNA extracted from leg muscles compared to DIA in the col5a1(+/‐) Het models. This peak current decrease in leg muscles mirrors what was seen in the mdx samples (Figure 1). SOL and EDL muscles exhibited current declines of 36.07±0.88% and 26.72±0.75%, respectively, averaging around 30% (p < 0.05). In contrast, electrochemical analysis showed a much smaller peak current decline in DNA extracted from DIA tissue, which exhibited a 13.87±0.14% Ip decrease in Het vs. WT samples. These data are consistent with DNA in the leg muscles more significantly impacted by the eliminated Col5a1 allele than muscles employed during respiration. The lower baseline WT currents prevalent in the leg muscle samples indicate that the guanine content in those tissues is affected based on the muscle function. Also, of note, only the DIA average Ip differences (Het vs. WT) were significant (p < 0.05) alone. SOL and EDL Ip differences were significant when combining the trend averages (p < 0.05) but were not statistically significant on an individual basis. It is important to note here that the muscle extraction differences are based in the disease pathologies, which are different for DMD vs. EDS. Not all mice exhibiting the DMD phenotype express pathology in these three muscle locations at the age where tissue was collected, which is why the gastrocnemius muscle was assayed for those samples. (a) Representative SWV plots for WT (black) or Het Col5a1 samples (red) from denoted tissue types. (b) Average Ip at +1.05V for the denoted tissue types. Error bars represent s.d. for n = 3. * denotes statistically significant difference (p < 0.05). We have previously reported similar declining peak currents when comparing DNA from BRCA1 KO and WT mice. There, the focus was on the KO treatment impacts on mtDNA through mutations and integrity, whereas here, total DNA was extracted. Despite the differences in DNA compared to the BRCA1 study, similar trends were seen here in terms of peak current decrease across samples, which is generally associated with guanine loss. To confirm this was the case, the SWV analysis was validated utilizing MS/MS. Tandem Mass Spectrometry Analysis To provide sensor‐based analysis validation and elucidate the genetic basis for the Ip changes when comparing WT to treatment DNA, we employed MS/MS to provide a more in‐depth base analysis. DNA was exposed to acid hydrolysis and following filtration, hydrolyzed samples were analyzed for quantifying and qualifying product ions employing calibrated MS/MS programs. In our previous report, we relied on monitoring guanine and 8‐oxoguanine (8‐oxoG) to validate the electrochemical responses [39]. To further explore the specific DNA changes underlying the electrochemical trends seen in the mdx and the col5a1(+/) mice here, we expanded our mass spectrometric base analyses to include all canonical bases as well as oxidative products 8‐oxoG for all samples and 4,6‐diamino‐5‐formamidopyrimidine (fapyadenine, FapyA) for mdx samples. Based on sensitivity limitations and Ru(bpy)3 2+/guanine electrochemical oxidation potential overlap, the sensor‐based method is best suited to provide guanine‐based analysis, but the importance of oxidative damage and adenine damage is increasingly recognized in genetic disorders. The accuracy of sequencing adenine lesions in somatic genomes remains insufficient [10, 11, 12, 13, 57, 58, 59, 60, 61, 62]. MS/MS analysis can remedy some of these limitations. Detection of FapyA can provide valuable insights into the extent of oxidative damage in DNA samples and can be more facilely detected using our protocols due to the unique mass fragments that are produced versus 8‐oxoadenine. Our MS/MS method and fragment analysis for FapyA is summarized in supporting information (Table S1, Figure S1). Figure 3 shows a sample LC‐MS/MS chromatogram for guanine analysis and summary percentage change plot for the remaining bases and oxidation products comparing BLK/10 WT to the mdx treatment. LC‐MS/MS chromatograms for remaining bases originating from a mdx sample are shown in Figures S2–3. (a) LC‐MS/MS chromatogram for guanine (152 → 135) detection from WT (solid) and mdx KO (dashed). (b) Percentage comparison showing denoted base content difference in mdx KO vs. WT samples. The chromatogram shows the quantifying ion transition peak area decrease for guanine as an example when comparing WT BLK/10 vs. mdx analysis. Other bases were detected and analyzed in the same manner to generate the percentage comparison plot in Figure 3b. That plot shows the percentage changes for the denoted bases following hydrolysis in the mdx KO samples compared to the BLK/10 WT counterpart samples. The plot shows that the guanine percentage decreased compared to WT, which is consistent with the SWV data as the electrochemical assay is heavily dependent on guanine content. Figure 4a‐b shows the analogous analyses for the three different tissues analyzed from the col5a1(+/‐) samples. Sensitivity precluded MS/MS analysis of FapyA while thymine analysis was only available for DIA tissues. (a) LC‐MS/MS chromatogram for guanine (152 → 135) detection from DIA (blue), EDL (black) and SOL (red). Solid is WT, dashed is Het col5a1(+/‐). (b) Percentage comparison showing denoted base content difference in Het col5a1(+/‐) vs. WT samples for denoted tissue types. Despite these limitations, the base analysis shines light on the genetic changes that produce the current changes upon SWV oxidation. Beyond guanine, the plot elucidates the types of base changes in the different muscle tissues due to the genetic alterations in the mice. The mdx model shows a loss in guanine and cytosine content with concurrent increases in adenine and thymine content accompanied by increases in both 8‐oxoG and FapyA oxidative lesions. FapyA levels increased 8.7±1.1% (p < 0.05) in these samples. This apparent transition between G:C to A:T base pairs is consistent with potential point mutations resulting from misrepair of initial oxidative lesions. This is consistent with overwhelmed base and nucleotide excision repair mechanisms attempting to reconcile extensive adenine and guanine damage under chronically high oxidative environments prompted by dystrophin glycoprotein complex dysfunction or collagen assembly disruption [63, 64, 65, 66, 67]. As the levels of oxidatively damaged bases increase, the likelihood that these lesions are misinterpreted during DNA replication also rises. For instance, 8‐oxoG can base pair with adenine instead of cytosine, leading to G:C to T:A transversion mutations [68]. Similarly, the presence of FapyA may disrupt normal base pairing, potentially resulting in A:T to G:C transition mutations [69]. In the Het col5a1(+/‐) mice, DIA DNA exhibited the least base composition differences compared to WT. The SOL and EDL leg muscle DNA showed more severe percentage changes in base composition compared to their WT counterparts. Consistent with the SWV analysis, this suggests that the leg muscles were more impacted by the Col5a1 mutation than the respiratory muscles. Specifically, the results here demonstrate a consistent decrease in both guanine and cytosine for all muscle types examined, albeit with less change in the DIA samples, which also were the only samples of the three to show a slight detectable increase in 8‐oxoG. Altogether, the results indicate that DIA may not undergo as significant damage as compared to the leg muscles in the EDS model. However, in both monitored EDS model leg muscles, a substantial decrease in guanine and cytosine was coupled with an approximate equal decline in 8‐oxoG. This is consistent with a mutation rate that differs from the rate of damage accumulation implying either overwhelmed repair machinery may be attempting to reconcile damage and/or factors other than oxidative damage, such as defects in DNA repair mechanisms or alterations in the cellular environment, may be the primary drivers of mutagenesis in the col5a1(+/‐) leg muscle tissues. Discussion Several mouse models have been used to both study these muscular disorders and research possible therapeutic targets [2, 3, 4, 8, 9]. The mdx mouse line has been extensively used as an isogenic model for DMD [1, 3]. The DMD gene is responsible for encoding dystrophin, a protein crucial for maintaining sarcolemmal stability and functionality in skeletal muscle [21, 67]. The mdx mouse recapitulates the dystrophin deficiency characteristic of DMD pathology through mutations in the DMD gene, which encodes the dystrophin protein vital for sarcolemma integrity [15]. Previous mouse transgenic models highlighted the role of collagen V in human EDS [7, 9], and highlighted the importance of the COL5a1 gene that is responsible for encoding the α1 chain on collagen type V. In mutant form, collagen fibril formation is disrupted [2]. The DNA extracted from the mdx KO mice exhibited significant oxidative damage, as evidenced by decreased guanine levels and increased 8‐oxoG levels outlined in Figure 3. col5a1(+/‐) mice exhibited significantly lower guanine and cytosine content, accompanied with concurrent decreases in 8‐oxoG oxidative damage as well. Base content decreases are consistent with mutations in those tissues [39, 41]. In the mdx samples, this was accompanied with increases in 8‐oxoG suggesting that the leg tissue captured here was exposed to oxidatively damaging conditions leading to the damaged guanine, and subsequent guanine loss. The guanine decrease was accompanied with increases in adenine/thymine, suggesting transversion mutations [68]. DNA from leg muscles in both mdx and col5a1(+/‐) mice was more severely affected than the DIA in col5a1(+/‐). The col5a1(+/‐) leg muscles exhibited lower guanine content but also decreased 8‐oxoG levels as well. With the increase in detected adenine levels, this is still consistent with oxidative damage leading to mutations in these samples, albeit with the oxidative damage occurring at a different rate or following a different process due to the decrease in oxidatively damaged base content. Taken together with the electrochemical SWV analysis, this shows that the murine genetic alterations result in a significant DNA mutation load in these specific tissues, which is consistent with phenotypes underlying DMD and EDS. Oxidative damage leads to increased genomic instability through generation of complex lesions and large genetic deletions [15]. Oxidative damage occurs in DMD during pathological conditions, leading to widespread instability [70]. Dystrophin deficiencies have been linked to continual membrane damage and cell necrosis, creating oxidative environments prompting DNA damage [67]. Reactive oxygen species directly modify DNA bases, with adenine and guanine most readily oxidized [57, 59, 71]. Resultant complex lesions overwhelm repair machinery, being improperly rejoined through error‐prone pathways causing point mutations or deletions [10, 12, 13, 62]. We have previously shown that changes in 8‐oxoG are accompanied with guanine mutations, but we did not previously assess for any adenine damage. Adenine damage quantification can address a critical gap in assessing oxidative damage loads and resultant genotype alterations [14, 72, 73]. While oxidative damage to guanine is well‐established, the importance of adenine damage is increasingly recognized, especially in neurological pathologies which bear oxidative stress hallmarks analogous to muscular dystrophies [57]. However, accuracy of sequencing adenine lesions in somatic genomes remains lacking, primarily due to amplification biases and specificity issues [11, 12, 57, 58, 59, 60, 61]. Common sequencing methods frequently fail to detect 8‐oxoA due to resemblance with native bases, prompting false negatives. Structurally similar oxidized purines, like 8‐oxoA and FapyA, can readily accumulate in highly oxidative environments yet evade identification [74, 75, 76, 77, 78]. However, mass spectrometry techniques can provide enhanced separation and sensitive identification of adenine damage [76]. Here, increases in FapyA in mdx DNA suggest that the oxidation damage in this muscular tissue follows a more complex pathway than simply guanine oxidative damage followed by mutations of those bases. This contrasts with most oxidative damage assessments focused predominately on the “guanine paradigm” lesions [76]; however, additional analysis is needed to fully grasp the genetic ramifications of this adenine damage pathway. Turning to the EDS model, pathogenic variants have been found in approximately 58% of COL5a1 genes sequenced from patients afflicted with this disease [5]. Phenotypes overlapping with classical or vascular EDS frequently exhibit pathogenic variants in COL5a1, the gene typically associated with these presentations [2, 79]. These overlapping phenotypes are consistent with an underlying collagen defect, as pathogenic COL5a1 variants disrupt collagen fibril assembly and cross‐linking, reducing functional collagen content and thereby altering extracellular matrix structure and tissue tensile strength [3, 6, 7]. COL5a1 is important in extracellular matrix formation and skeletal muscle function, forming part of the extracellular skeletal muscle matrix that can affect the passive muscle stiffness and joint flexibility [2]. Genetic analysis on Australian football players showed a strong correlation between a single nucleotide polymorphism in COL5a1 and muscle injury severity and function [80]. Our results here highlight that variation in the COL5a1gene has a clear impact on the overall genetic makeup of these muscular tissues that likely impacts muscle injury severity and function [2, 79], and are consistent with COL5a1 variations leading to EDS pathogenesis. The electrochemical approach here provides a facile means to investigate DNA damage and composition variations via a rapid ‘first pass’ assessment. The lower oxidation potential renders guanine the primary marker of global DNA changes [30, 31, 51, 71, 81]. The oxidation potential overlap with Ru(bpy)3 2+ makes the electrochemical analysis sensitive to guanine content, which can fluctuate due to its oxidation or mutation to other bases. While other transition metal catalysts can be employed to potentially probe 8oxoG [82], use of Ru(bpy)3 2+ to probe DNA has been demonstrated as a straightforward rapid, cost‐effective means to differentiate WT from mutated DNA samples [39, 40, 41, 83]. Similar to this report, we also previously utilized LC‐MS/MS as a validation technique to show that the electrochemical output was largely related to guanine content or 8‐oxoG in the analyzed samples [39]. A major goal of this work was to expand DNA base monitoring beyond guanine and 8‐oxoG to more fully validate hypotheses regarding accumulated damage and mutation loads that may lead to the SWV outputs. Since most DNA damage sequencing methods require DNA amplification that can prohibit the quantification of levels of DNA damage [11], by enabling detection of oxidative lesions like 8‐oxoG and FapyA, the combined electrochemical and mass spectrometry approach may provide a more effective alternative to traditional sequencing methods that may exhibit amplification biases and limited assessment of genome structural variations [39, 84, 85]. The versatility of this analysis approach allows identification of trace damage that may be undetectable through traditional approaches. Consequently, adopting this analytical platform to profile DNA instability in DMD and EDS models, both of which are characterized by substantial oxidative genetic character [65, 66, 67], allows clearer connections between patterns of oxidative stress, resultant DNA damage, and mechanistic contributors to tissue degeneration. Conclusions The complementary SWV and MS/MS analyses outlined here provide powerful proof of concept assessment tools for probing biologically sourced DNA, here elucidating the genetic underpinnings of skeletal‐muscle genetic disorders DMD and EDS. The rapid electrochemical assessment approach overcomes the limitations of traditional sequencing methods, enabling the electrochemical detection of DNA variances followed by direct quantification of base changes and oxidative lesions utilizing MS analysis. Our results highlight the presence of oxidative damage in these tissues, and its role in driving genomic instability in DMD and likely EDS as well. By comparing oxidative lesion distribution and base composition changes, we gain insights into the divergent stress stimuli and pathogenic mechanisms underlying these disorders. The integration of genotypic and phenotypic data, as enabled by this complementary approach, provides a more complete picture of the complex interplay between genetic mutations, cellular dysfunction, and tissue‐level abnormalities. Future studies will focus on further refining this technique and applying it to larger cohorts of animal models and patient samples to enhance the statistical power of the approach and validate its clinical utility and potential for personalized medicine approaches. Supporting Information Additional supporting information can be found online in the Supporting Information section. Funding This work was supported by National Science Foundation (1851844), and National Institutes of Health (R33 AR078100). Conflicts of Interest The authors declare no conflicts of interest. Supporting information Supplementary Material